Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Factor Bioscience to Deliver Seven Presentations at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting | ||
By: PR Newswire Association LLC. - 23 Apr 2024 | Back to overview list |
|
-Factor to reveal novel mRNA-engineered immunosuppressive allogeneic cells. -Presentations will include latest data from Factor's library of novel ionizable lipids, including delivery of mRNA to T cells and monocytes. -Factor to present progress on multi-cell type iPS cell strategy for solid-tumor targeting, including mRNA engineering for enhanced cancer-cell killing. CAMBRIDGE, Mass., April 23, 2024 /PRNewswire/ -- Factor Bioscience Inc., a Cambridge-based biotechnology company focused on developing mRNA and cell-engineering technologies, announced its participation in the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting to be held in Baltimore, MD from May 7-11, 2024. Factor will deliver seven presentations, representing the company's most expansive presentation of data to date. "Factor will deliver seven presentations, representing the company's most expansive presentation of data to date." "2024 marks the fifth year that Factor will present our latest data at the Annual Meeting of the ASGCT," said Dr. Matt Angel, Co-Founder, Chairman and CEO of Factor. "This year promises to be particularly exciting, as we present our progress on deploying the powerful mRNA cell-engineering technologies that we have built at Factor over the last decade." Dr. Kyle Garland, Director of Translational Science at Factor, commented, "We have been working hard over the last year to address several critical needs in our industry, including tissue-targeted delivery of nucleic acids, durable allogeneic cell therapies, and effective approaches for targeting solid tumors. We look forward to presenting our results in these and other areas next month at the ASGCT Annual Meeting." Details of the presentations are below:
For more information about the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting, visit annualmeeting.asgct.org. About Factor Bioscience
View original content to download multimedia:https://www.prnewswire.com/news-releases/factor-bioscience-to-deliver-seven-presentations-at-the-american-society-of-gene--cell-therapy-asgct-27th-annual-meeting-302124039.html SOURCE Factor Bioscience |
||
|
||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |